Skip to main navigation Skip to search Skip to main content

Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach

  • The SafeBoosC-III Trial Group
  • University of Copenhagen
  • University of Southern Denmark
  • Hospital Universitario La Paz
  • University of Warsaw
  • Loma Linda University Health
  • University of Lausanne
  • NHS Greater Glasgow and Clyde
  • Marmara University
  • Wrocław Medical University
  • Medical Center UJASTEK
  • Hospital de Cruces
  • Grand Hopital de Charleroi
  • University of Zurich
  • Gazi University
  • Heraklion University Hospital
  • Presidio Ospedaliero S.Anna
  • Alexandra University and State Maternity Hospital
  • Zhejiang University
  • University of Patras
  • ENT-University Hospital Graz
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS
  • KU Leuven
  • Fudan University
  • University of Freiburg
  • Uludag University
  • Hospital Universitario Marques de Valdecilla
  • Jan Biziel University Hospital
  • Charles University
  • The Institute for the Care of Mother and Child
  • Guangzhou Women and Children’s Medical Center
  • Mountainside Medical Center
  • CHU Tivoli
  • NHS Lanarkshire
  • Specialist Hospital No. 2 in Bytom
  • George Papanikolaou General Hospital of Thessaloniki
  • Aalborg University
  • Hospital Universitario Virgen de las Nieves
  • University of Texas Southwestern Medical Center
  • Maternal and Child Health Care Hospital of Hainan Province
  • General Hospital St. Jan
  • Complejo Hospitalario San Carlos
  • University of Utah
  • Kantonsspital Luzern
  • Ospedalo Fillipo del Ponte
  • Istanbul Basaksehir Cam and Sakura City Hospital
  • Hospital Clínic de Barcelona
  • IRCCS Fondazione Ca'Granda – Ospedale Maggiore Policlinico - Milano
  • Complejo Hospitalario Universitario de Santiago
  • H. Universitario Juan XXIII De Tarragona
  • University of Geneva
  • Hospital Unversitarie Puerta Del Mar (Cadiz)
  • Aarhus University
  • Liege Rocourt
  • Centre Hospitalier Regional de La Citadelle
  • Hospital De Sant Joan De Deu
  • Szpital Uniwersytecki w Krakowie
  • Hospital Universitario 12 de Octubre
  • St. John's National Academy of Health Sciences
  • Hospital Universitario Miguel Servet
  • Longgang District Central Hospital
  • University of Oslo
  • Ankara City Hospital Maternity Hospital
  • University of Medical Sciences Poznan
  • Guangxi Maternal and Child Healthcare Hospital
  • Xiamen Children's Hospital
  • The People’s Hospital of Dehong autonomous prefecture

Research output: Contribution to journal › Article › peer-review

Abstract

Background: Data monitoring of clinical trials is a tool aimed at reducing the risks of random errors (e.g. clerical errors) and systematic errors, which include misinterpretation, misunderstandings, and fabrication. Traditional ‘good clinical practice data monitoring’ with on-site monitors increases trial costs and is time consuming for the local investigators. This paper aims to outline our approach of time-effective central data monitoring for the SafeBoosC-III multicentre randomised clinical trial and present the results from the first three central data monitoring meetings. Methods: The present approach to central data monitoring was implemented for the SafeBoosC-III trial, a large, pragmatic, multicentre, randomised clinical trial evaluating the benefits and harms of treatment based on cerebral oxygenation monitoring in preterm infants during the first days of life versus monitoring and treatment as usual. We aimed to optimise completeness and quality and to minimise deviations, thereby limiting random and systematic errors. We designed an automated report which was blinded to group allocation, to ease the work of data monitoring. The central data monitoring group first reviewed the data using summary plots only, and thereafter included the results of the multivariate Mahalanobis distance of each centre from the common mean. The decisions of the group were manually added to the reports for dissemination, information, correcting errors, preventing furture errors and documentation. Results: The first three central monitoring meetings identified 156 entries of interest, decided upon contacting the local investigators for 146 of these, which resulted in correction of 53 entries. Multiple systematic errors and protocol violations were identified, one of these included 103/818 randomised participants. Accordingly, the electronic participant record form (ePRF) was improved to reduce ambiguity. Discussion: We present a methodology for central data monitoring to optimise quality control and quality development. The initial results included identification of random errors in data entries leading to correction of the ePRF, systematic protocol violations, and potential protocol adherence issues. Central data monitoring may optimise concurrent data completeness and may help timely detection of data deviations due to misunderstandings or fabricated data.

Original languageEnglish
Article number160
JournalBMC Medical Research Methodology
Volume21
Issue number1
DOIs
Publication statusPublished - Dec 2021

Keywords

  • Central monitoring
  • Clinical trials
  • Data deviations
  • Data quality
  • Mahalanobis distance
  • Missing data

Fingerprint

Dive into the research topics of 'Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach'. Together they form a unique fingerprint.

Cite this